Evidence map›Paper›PMID 29216444›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

Under Pressure to Clarify Pulmonary Hypertension Clinical Risk.

Bradley A Maron, Bradley M Wertheim, Mark T Gladwin

Abstract readEditorialComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.American journal of respiratory and critical care medicine · 2020
    Article
  7. Article
  8. Pathophysiology of Sickle Cell Disease.Annual review of pathology · 2019
    Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Bradley A Maron1 Division of Cardiovascular Medicine Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts.
Bradley M Wertheim3 Division of Pulmonary and Critical Care Medicine Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts.
Mark T Gladwin4 University of Pittsburgh Medical Center and.

Funding

RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertensionR01HL139613 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Sirano Dhe-Paganon, Bradley Maron · 2018 to 2026
$4.1M
Aldosterone impairs endothelin B-dependent synthesis of nitric oxide to promote pK08HL111207 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MARON, BRADLEY · 2013 to 2017
$754k
Fibrosome regulation by aldosterone in pulmonary vascular diseaseR56HL131787 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MARON, BRADLEY · 2017 to 2017
$445k
NHLBI NIH HHS K08 HL111207NHLBI NIH HHS R01 HL139613NHLBI NIH HHS R56 HL131787NHLBI NIH HHS T32 HL007633
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Arterial PressureHypertension, PulmonaryHumansPulmonary Artery

Identifiers

PMID29216444
PMCPMC5821912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.